Literature DB >> 17488688

The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis.

Haikun Wang1, Song Chen, Yongmei Chen, Huizhen Wang, Hui Wu, Hongmei Tang, Weipeng Xiong, Jing Ma, Yehua Ge, Qingxian Lu, Daishu Han.   

Abstract

BACKGROUND AND OBJECTIVES: The molecular mechanisms regulating megakaryocytopoiesis and hemostasis remain largely unknown. The Tyro 3 subfamily of receptor tyrosine kinases (RTK), which is composed of three members (Tyro 3, Axl and Mer), plays important roles in various tissues, such as those in the nervous, immune and reproductive systems. Here, we investigate the roles of the Tyro 3 RTK subfamily in regulating megakaryocytopoiesis and hemostasis. DESIGN AND METHODS: Single, double, and triple knock-out mice for the three Tyro 3 RTK were used in the study. Bleeding time, platelet count, megakaryocyte count, megakaryocyte ploidy, rate of proplatelet formation, platelet aggregation and ATP release were used as criteria to evaluate hemostasis, megakaryocytopoiesis and platelet function.
RESULTS: Mice lacking all three receptors had impaired hemostasis and mild thrombocytopenia, which may be due to platelet dysfunction and defective megakaryocytopoiesis. Mice lacking different combinations of two receptors of the Tyro 3 RTK subfamily had normal platelet counts in peripheral blood, but exhibited impaired hemostasis and platelet function. Although knock-out mice for any single receptor had normal hemostasis and megakaryocytopoiesis, they exhibited a mild platelet dysfunction. INTERPRETATION AND
CONCLUSIONS: The Tyro 3 RTK subfamily plays important roles in regulating hemostasis, megakaryocytopoiesis and platelet function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488688     DOI: 10.3324/haematol.10939

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  17 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

3.  UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.

Authors:  Deborah DeRyckere; Alisa B Lee-Sherick; Madeline G Huey; Amanda A Hill; Jeffrey W Tyner; Kristen M Jacobsen; Lauren S Page; Gregory G Kirkpatrick; Fatma Eryildiz; Stephanie A Montgomery; Weihe Zhang; Xiaodong Wang; Stephen V Frye; H Shelton Earp; Douglas K Graham
Journal:  Clin Cancer Res       Date:  2016-09-20       Impact factor: 12.531

4.  Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.

Authors:  Xiao-Han Qu; Jin-Lu Liu; Xin-Wen Zhong; X I Li; Qi-Gang Zhang
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

5.  Reprogramming of Sertoli cells to fetal-like Leydig cells by Wt1 ablation.

Authors:  Lianjun Zhang; Min Chen; Qing Wen; Yaqiong Li; Yaqing Wang; Yanbo Wang; Yan Qin; Xiuhong Cui; Lin Yang; Vicki Huff; Fei Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

6.  TAM receptors and the regulation of erythropoiesis in mice.

Authors:  Hongmei Tang; Song Chen; Haikun Wang; Hui Wu; Qingxian Lu; Daishu Han
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

Review 7.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 8.  Axl as a mediator of cellular growth and survival.

Authors:  Haley Axelrod; Kenneth J Pienta
Journal:  Oncotarget       Date:  2014-10-15

Review 9.  Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.

Authors:  Jeffrey L Curtis; Jill C Todt; Bin Hu; John J Osterholzer; Christine M Freeman
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.

Authors:  A B Lee-Sherick; K M Eisenman; S Sather; A McGranahan; P M Armistead; C S McGary; S A Hunsucker; J Schlegel; H Martinson; C Cannon; A K Keating; H S Earp; X Liang; D DeRyckere; D K Graham
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.